Not applicableStudy completedNCT06461598What this trial is testingSignature for Precise Chemosensitivity Prediction in PDACWho this might be right forPancreatic Cancer Ruijin Hospital 365
Early research (Phase 1)Not Yet RecruitingNCT07360314What this trial is testingAnti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors EMD Serono Research & Development Institute, Inc. 138
Not applicableTemporarily pausedNCT03444948What this trial is testingA Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Centre hospitalier de l'Université de Montréal (CHUM) 108
Not applicableUnknownNCT05228808What this trial is testingImmunohistochemical Expression of PD-L1 in Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma Sohag University 50
Not applicableNot Yet RecruitingNCT06276803What this trial is testingThe LINFU® U.S. Registry for the in the General Population Without Risk FactorsWho this might be right forPancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia Adenocyte, LLC 500
Not applicableUnknownNCT02607826What this trial is testingShort-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsWho this might be right forCholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more University Hospital Tuebingen 298
Not applicableLooking for participantsNCT02757859What this trial is testingHigh Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by SurgeryWho this might be right forAcinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more Sidney Kimmel Cancer Center at Thomas Jefferson University 845
Testing effectiveness (Phase 2)Looking for participantsNCT05048524What this trial is testingPeri-operative SLOG for Localized Pancreatic CancerWho this might be right forPancreatic Ductal AdenocarcinomaPancreas Cancer National Health Research Institutes, Taiwan 64
Not applicableNot Yet RecruitingNCT06616688What this trial is testingInnovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC) IRCCS San Raffaele 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03806309What this trial is testingOSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDACWho this might be right forPancreatic Ductal AdenocarcinomaLocally Advanced CancerMetastatic Cancer GERCOR - Multidisciplinary Oncology Cooperative Group 106
Early research (Phase 1)Study completedNCT03811652What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsWho this might be right forNon Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more MedImmune LLC 8
Not applicableUnknownNCT04883450What this trial is testingPRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic CancerWho this might be right forPancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC) Kaiser Permanente 126
Testing effectiveness (Phase 2)Ended earlyNCT06069778What this trial is testingSafety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer BioNTech SE 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06904378What this trial is testingONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Washington University School of Medicine 61
Testing effectiveness (Phase 2)WithdrawnNCT02575508What this trial is testingPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWho this might be right forColon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more Roswell Park Cancer Institute
Not applicableUnknownNCT04525209What this trial is testingIntegrative Proteomic Characterization of Pancreatic Ductal AdenocarcinomaWho this might be right forTumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics Ruijin Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06608927What this trial is testingStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Arcus Biosciences, Inc. 610
Testing effectiveness (Phase 2)Looking for participantsNCT07163273What this trial is testingMonthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Northwell Health 41
Testing effectiveness (Phase 2)Looking for participantsNCT05706129What this trial is testingAssess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more ITM Oncologics GmbH 270
Testing effectiveness (Phase 2)Looking for participantsNCT04887805What this trial is testingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic CancerWho this might be right forAdvanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more City of Hope Medical Center 28